Paper36722665
Omecamtiv mecarbil augments cardiomyocyte contractile activity both at resting and systolic Ca2+ levels.
Ráduly AP and 9 others. ESC Heart Fail, 2023. Cited by 9 papers, by iCite.
Cite this record
ConductScience Library. Omecamtiv mecarbil augments cardiomyocyte contractile activity both at resting and systolic Ca2+ levels. Papers, record 36722665. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36722665
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Omecamtiv mecarbil augments cardiomyocyte contractile activity both at resting and systolic Ca2+ levels.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Myocytes, Cardiac | Major topic |
| Heart Failure | Major topic |
| Animals | |
| Dogs | |
| Stroke Volume | |
| Simendan | |
| Myosins | |
| Urea |
Source PubMed
References30
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 28668303 | Ca2+-activated Cl- current is antiarrhythmic by reducing both spatial and temporal heterogeneity of cardiac repolarization. | J Mol Cell Cardiol | 2017 | https://conductscience.org/library/papers/28668303 | PubMed |
| 2 | 27012405 | Acute Treatment With Omecamtiv Mecarbil to Increase Contractility in Acute Heart Failure: The ATOMIC-AHF Study. | J Am Coll Cardiol | 2016 | https://conductscience.org/library/papers/27012405 | PubMed |
| 3 | 16116344 | Two inotropes with different mechanisms of action: contractile, PDE-inhibitory and direct myofibrillar effects of levosimendan and enoximone. | J Cardiovasc Pharmacol | 2005 | https://conductscience.org/library/papers/16116344 | PubMed |
| 4 | 26140433 | The novel cardiac myosin activator omecamtiv mecarbil increases the calcium sensitivity of force production in isolated cardiomyocytes and skeletal muscle fibres of the rat. | Br J Pharmacol | 2015 | https://conductscience.org/library/papers/26140433 | PubMed |
| 5 | 32035892 | Omecamtiv Mecarbil in Chronic Heart Failure With Reduced Ejection Fraction: Rationale and Design of GALACTIC-HF. | JACC Heart Fail | 2020 | https://conductscience.org/library/papers/32035892 | PubMed |
| 6 | 21856481 | The effects of the cardiac myosin activator, omecamtiv mecarbil, on cardiac function in systolic heart failure: a double-blind, placebo-controlled, crossover, dose-ranging phase 2 trial. | Lancet | 2011 | https://conductscience.org/library/papers/21856481 | PubMed |
| 7 | 25680381 | Omecamtiv Mecarbil modulates the kinetic and motile properties of porcine β-cardiac myosin. | Biochemistry | 2015 | https://conductscience.org/library/papers/25680381 | PubMed |
| 8 | 27914656 | Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure (COSMIC-HF): a phase 2, pharmacokinetic, randomised, placebo-controlled trial. | Lancet | 2016 | https://conductscience.org/library/papers/27914656 | PubMed |
| 9 | 14751410 | The effects of levosimendan and OR-1896 on isolated hearts, myocyte-sized preparations and phosphodiesterase enzymes of the guinea pig. | Eur J Pharmacol | 2004 | https://conductscience.org/library/papers/14751410 | PubMed |
| 10 | 15750836 | Sarcomeric determinants of striated muscle relaxation kinetics. | Pflugers Arch | 2005 | https://conductscience.org/library/papers/15750836 | PubMed |
| 11 | 24520162 | Small molecule-mediated refolding and activation of myosin motor function. | Elife | 2014 | https://conductscience.org/library/papers/24520162 | PubMed |
| 12 | 1880816 | A novel positive inotropic substance enhances contractility without increasing the Ca2+ transient in rat myocardium. | J Mol Cell Cardiol | 1991 | https://conductscience.org/library/papers/1880816 | PubMed |
| 13 | 25068717 | Analytical comparison of natural and pharmaceutical ventricular myosin activators. | Biochemistry | 2014 | https://conductscience.org/library/papers/25068717 | PubMed |
| 14 | 21856480 | Dose-dependent augmentation of cardiac systolic function with the selective cardiac myosin activator, omecamtiv mecarbil: a first-in-man study. | Lancet | 2011 | https://conductscience.org/library/papers/21856480 | PubMed |
| 15 | 28792844 | TRPA1 ion channel stimulation enhances cardiomyocyte contractile function via a CaMKII-dependent pathway. | Channels (Austin) | 2017 | https://conductscience.org/library/papers/28792844 | PubMed |
| 16 | 21784540 | Levosimendan: molecular mechanisms and clinical implications: consensus of experts on the mechanisms of action of levosimendan. | Int J Cardiol | 2012 | https://conductscience.org/library/papers/21784540 | PubMed |
| 17 | 28940010 | Frequency-dependent effects of omecamtiv mecarbil on cell shortening of isolated canine ventricular cardiomyocytes. | Naunyn Schmiedebergs Arch Pharmacol | 2017 | https://conductscience.org/library/papers/28940010 | PubMed |
| 18 | 20498236 | Improvement of cardiac function by a cardiac Myosin activator in conscious dogs with systolic heart failure. | Circ Heart Fail | 2010 | https://conductscience.org/library/papers/20498236 | PubMed |
| 19 | 25260618 | Effects of a myofilament calcium sensitizer on left ventricular systolic and diastolic function in rats with volume overload heart failure. | Am J Physiol Heart Circ Physiol | 2014 | https://conductscience.org/library/papers/25260618 | PubMed |
| 20 | 8384421 | Enantiomeric dissection of the effects of the inotropic agent, EMD 53998, in single cardiac myocytes. | Am J Physiol | 1993 | https://conductscience.org/library/papers/8384421 | PubMed |
Cited by9
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42806179 | Substrate-Dependent Pro- and Antiarrhythmic Action of Omecamtiv Mecarbil at the Ventricular and Atrial Level: Insights from a Langendorff-Perfused Rabbit Heart Model. | Cardiovasc Toxicol | 2026 | https://conductscience.org/library/papers/42806179 | PubMed |
| 41384329 | Diffusion Tensor CMR Assessment of the Microstructural Response to Dobutamine Stress in Health and Comparison With Patients With Recovered Dilated Cardiomyopathy. | Circ Cardiovasc Imaging | 2026 | https://conductscience.org/library/papers/41384329 | PubMed |
| 40831223 | Insights from electromechanical simulations to assess omecamtiv mecarbil efficacy in heart failure. | J Physiol | 2026 | https://conductscience.org/library/papers/40831223 | PubMed |
| 39927371 | Pharmacodynamics of single-dose omecamtiv mecarbil administered intravenously in clinically healthy cats. | Open Vet J | 2024 | https://conductscience.org/library/papers/39927371 | PubMed |
| 39802175 | Myosin activator omecamtiv mecarbil exhibits divergent inotropic and lusitropic effects in cardiac slices from patients with heart failure. | J Mol Cell Cardiol Plus | 2023 | https://conductscience.org/library/papers/39802175 | PubMed |
| 38566963 | Omecamtiv Mecarbil in the treatment of heart failure: the past, the present, and the future. | Front Cardiovasc Med | 2024 | https://conductscience.org/library/papers/38566963 | PubMed |
| 38338853 | Current Approaches to Worsening Heart Failure: Pathophysiological and Molecular Insights. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38338853 | PubMed |
| 37239022 | Characterization of Stimulatory Action on Voltage-Gated Na+ Currents Caused by Omecamtiv Mecarbil, Known to Be a Myosin Activator. | Biomedicines | 2023 | https://conductscience.org/library/papers/37239022 | PubMed |
| 36722665 | Omecamtiv mecarbil augments cardiomyocyte contractile activity both at resting and systolic Ca2+ levels. | ESC Heart Fail | 2023 | https://conductscience.org/library/papers/36722665 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| MYH14 | 79784 | PubTator's text mining | https://conductscience.org/library/genes/79784 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36722665
GET https://conductscience.org/api/papers/v1/36722665/references?page=2